ValueSet Comparison between http://hl7.org/fhir/us/core/ValueSet/us-core-goal-description vs http://hl7.org/fhir/us/core/ValueSet/us-core-goal-description

Messages

Metadata

Name	Value		Comments
compose.inactive
compose.lockedDate
copyright	1. This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement. 2. This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC ® is a registered United States trademark of Regenstrief Institute, Inc
date	2021-11-22	2022-09-29	Values Differ
description	Concepts from CPT and LOINC code systems that can be used to indicate the goal.
experimental		false	Added the item 'false'
immutable
jurisdiction
jurisdiction[0]	urn:iso:std:iso:3166#US
name	USCoreGoalCodes
publisher	HL7 International - Cross-Group Projects
purpose
status	active
title	US Core Goal Codes
url	http://hl7.org/fhir/us/core/ValueSet/us-core-goal-description
version	5.0.1	6.0.0-ballot	Values Differ

Definition

Item	Property		Value		Comments
include	http://snomed.info/sct
include	http://loinc.org

Expansion

Code	Display		Comments
1-8	Acyclovir [Susceptibility]
10-9	Amdinocillin [Susceptibility] by Serum bactericidal titer
100-8	Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)
1000-9	DBG Ab [Presence] in Serum or Plasma from Blood product unit
10000-8	R wave duration in lead AVR
100002-5	Specimen care is maintained
100003-3	Team communication is maintained throughout care
100004-1	Demonstrates knowledge of the expected psychosocial responses to the procedure
100005-8	Demonstrates knowledge of nutritional management related to the procedure
100006-6	Demonstrates knowledge of medication management
100007-4	Demonstrates knowledge of pain management
100008-2	Demonstrates knowledge of wound management
100009-0	Demonstrates knowledge of the procedure and expected results
10001-6	R wave duration in lead I
100010-8	No injury related to procedure equipment, medical supplies, or instrumentation
100011-6	No injury related to an electrical source
100012-4	Participates in decisions affecting the patient's plan of care
100013-2	Participates in the discharge process
100014-0	Psychosocial health is maintained at or improved from baseline
100015-7	No injury related to positioning due to care or procedure
100016-5	No injury related to a laser source
100017-3	Perioperative nursing data set outcomes panel [PNDS]
100018-1	Hospice care Note
100019-9	ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10002-4	R wave duration in lead II
100020-7	GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100021-5	GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100022-3	IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100023-1	IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100024-9	SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100025-6	SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100026-4	MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100027-2	SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100028-0	FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
100029-8	Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method
10003-2	R wave duration in lead III
100030-6	Axis I: Temporal aspects score [Mainz Pain Staging System]
100031-4	Axis II: Spatial aspects score [Mainz Pain Staging System]
100032-2	Axis III: Drug taking behavior score [Mainz Pain Staging System]
100033-0	Axis IV: Utilization of the health care system score [Mainz Pain Staging System]
100034-8	Provider of automated external defibrillator use
100035-5	Exam finding location of Chest
100036-3	Exam finding location of Lung
100037-1	Patient contact disposition EMS unit
100038-9	Patient evaluation disposition EMS unit
100039-7	Crew disposition for patient care EMS unit
10004-0	R wave duration in lead V1
100040-5	Patient transport disposition EMS unit
100041-3	Aminoglycoside [Susceptibility]
100042-1	Atovaquone [Susceptibility]
100043-9	Azithromycin+Ethambutol [Susceptibility]
100044-7	Cefcapene [Susceptibility]
100045-4	Cefozopran [Susceptibility]
100046-2	Cefquinome [Susceptibility]
100047-0	Cefteram [Susceptibility]
100048-8	Clarithromycin+Ethambutol [Susceptibility]
100049-6	Eravacycline [Susceptibility]
10005-7	R wave duration in lead V2
100050-4	Erythromycin+Ethambutol [Susceptibility]
100051-2	Ethambutol+rifAMPin [Susceptibility]
100052-0	Flomoxef [Susceptibility]
100053-8	Fluoroquinolone [Susceptibility]
100054-6	Gamithromycin [Susceptibility]
100055-3	Optochin [Susceptibility]
100056-1	Panipenem [Susceptibility]
100057-9	Prothionamide [Susceptibility]
100058-7	Prulifloxacin [Susceptibility]
100059-5	Rifapentine [Susceptibility]
10006-5	R wave duration in lead V3
100060-3	Tildipirosin [Susceptibility]
100061-1	Tosufloxacin [Susceptibility]
100062-9	Standard Dermatology Outcome Measures panel
100063-7	Primary skin concern
100064-5	Itch severity Reporting Period - Reported
100065-2	Satisfied with treatment
100066-0	Specular microscopy panel
100067-8	Eye Image magnification
100068-6	Right eye Fixation point [Angle]
100069-4	Left eye Fixation point [Angle]
10007-3	R wave duration in lead V4
100070-2	Right cornea Cell density
100071-0	Left cornea Cell density
100072-8	Right cornea Coefficient of variation
100073-6	Left cornea Coefficient of variation
100074-4	Right cornea Hexagonality
100075-1	Left cornea Hexagonality
100076-9	Right cornea Endothelial cells counted
100077-7	Left cornea Endothelial cells counted
100078-5	Right cornea Endothelial cell area.min
100079-3	Left cornea Endothelial cell area.min
10008-1	R wave duration in lead V5
100080-1	Right cornea Endothelial cell area.max
100081-9	Left cornea Endothelial cell area.max
100082-7	Right cornea Endothelial cell area.mean
100083-5	Left cornea Endothelial cell area.mean
100084-3	Right cornea Cell area.standard deviation
100085-0	Left cornea Cell area.standard deviation
100086-8	Right cornea Type of Analysis method by Specular microscopy
100087-6	Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot
100088-4	Taenia solium larva Ab bands panel - Serum by Immunoblot
100089-2	Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot
10009-9	R wave duration in lead V6
100090-0	Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot
100091-8	Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay
100092-6	Trypanosoma cruzi Ab bands panel - Serum by Immunoblot
100093-4	Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot
100094-2	Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot
100095-9	Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot
100096-7	Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot
100097-5	Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot
100098-3	Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot
100099-1	Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot
1001-7	DBG Ab [Presence] in Serum or Plasma from Donor
10010-7	R' wave amplitude in lead AVF
100100-7	Fasciola sp IgG Ab [Presence] in Serum by Immunoassay
100101-5	Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot
100102-3	Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot
100103-1	Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot
100104-9	Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot
100105-6	Filaria IgG and IgM panel - Serum
100106-4	Filaria IgG Ab [Presence] in Serum by Immunoassay
100107-2	Leishmania sp IgG Ab [Presence] in Serum by Immunoassay
100108-0	Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay
100109-8	Leishmania sp Ab bands panel - Serum by Immunoblot
10011-5	R' wave amplitude in lead AVL
100110-6	Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot
100111-4	Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot
100112-2	Fasciola sp Ab bands panel - Serum by Immunoblot
100113-0	Helicobacter pylori Ab panel - Serum
100114-8	Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot
100115-5	Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot
100116-3	Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot
100117-1	Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot
100118-9	Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot
100119-7	Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot
10012-3	R' wave amplitude in lead AVR
100120-5	Chlamydia trachomatis Ab panel - Serum
100121-3	Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay
100122-1	Chlamydophila pneumoniae Ab panel - Serum
100123-9	Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay
100124-7	Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay
100125-4	Chlamydophila psittaci Ab panel - Serum
100126-2	Bordetella pertussis Ab.IgG panel - Serum
100127-0	Campylobacter sp Ab panel - Serum
100128-8	Cryptococcus sp Ag panel - Serum
100129-6	Schistosoma sp Ab [Titer] in Serum by Hemagglutination
10013-1	R' wave amplitude in lead I
100130-4	Schistosoma mansoni Ab [Presence] in Serum by Immunoblot
100131-2	Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot
100132-0	Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot
100133-8	Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot
100134-6	Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot
100135-3	Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot
100136-1	Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot
100137-9	Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot
100138-7	Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot
100139-5	Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot
10014-9	R' wave amplitude in lead II
100140-3	Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot
100141-1	Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot
100142-9	Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot
100143-7	Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot
100144-5	Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot
100145-2	Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot
100146-0	Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot
100147-8	Toxoplasma gondii Ab bands panel - Serum by Immunoblot
100148-6	Schistosoma sp Ab bands panel - Serum by Immunoblot
100149-4	6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma
10015-6	R' wave amplitude in lead III
100150-2	6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma
100151-0	6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma
100152-8	6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine
100153-6	6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine
100154-4	Specimen collection supervision level
100155-1	Left cornea Type of Analysis method by Specular microscopy
100156-9	SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection
100157-7	SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing
100158-5	Microalbumin [Mass/volume] in Urine collected for unspecified duration
100159-3	Knee Society Score pre-op panel [Knee Society Score]
10016-4	R' wave amplitude in lead V1
100160-1	Knee replacement
100161-9	Charnley Functional Classification
100162-7	Knee alignment W standing X-ray measured
100163-5	Knee medial AndOr lateral instability W full extension
100164-3	Knee AP instability W 90 degree flexion
100165-0	Knee range of motion
100166-8	Flexion contracture range of Knee
100167-6	Extensor lag range of Knee
100168-4	Knee pain severity with level walking
100169-2	Knee pain severity with stairs or inclines
10017-2	R' wave amplitude in lead V2
100170-0	Knee feels normal
100171-8	Satisfaction with level of knee pain while sitting
100172-6	Satisfaction with level of knee pain while lying in bed
100173-4	Satisfaction with knee function while getting out of bed
100174-2	Satisfaction with knee function while performing light household duties
100175-9	Satisfaction with knee function while performing recreational activities
100176-7	Expect surgery to relieve pain
100177-5	Expect surgery will improve ability to perform activities of daily living
100178-3	Expect surgery will improve ability to perform leisure, recreational, or sports activities
100179-1	Walk without assistive mobility devices
10018-0	R' wave amplitude in lead V3
100180-9	Assistive mobility devices used
100181-7	Assistive mobility devices used due to health condition
100182-5	Duration of standing before sitting due to knee discomfort
100183-3	Duration of walking before stopping due to knee discomfort
100184-1	How bothersome is knee when walking on an uneven surface
100185-8	How bothersome is knee when turning or pivoting leg
100186-6	How bothersome is knee when climbing up or down a flight of stairs
100187-4	How bothersome is knee when getting up from a low seat without armrests
100188-2	How bothersome is knee when getting into or out of a car
100189-0	How bothersome is knee when moving laterally
10019-8	R' wave amplitude in lead V4
100190-8	How bothersome is knee when climbing a ladder or step stool
100191-6	How bothersome is knee when carrying a bag for one block
100192-4	How bothersome is knee when squatting
100193-2	How bothersome is knee when kneeling
100194-0	How bothersome is knee when running
100195-7	Pain severity--during activity
100196-5	Pre-op total score [Knee Society Score]
100197-3	Exercise activity and pain severity panel
100198-1	Pre-op objective knee indicators score [Knee Society Score]
100199-9	Pre-op symptoms score [Knee Society Score]
1002-5	DBG Ab [Presence] in Serum or Plasma
10020-6	R' wave amplitude in lead V5
100200-5	Pre-op patient expectations score [Knee Society Score]
100201-3	Pre-op functional activities score [Knee Society Score]
100202-1	Pre-op discretionary knee activities score [Knee Society Score]
100203-9	Knee Society Score post-op panel [Knee Society Score]
100204-7	Accuracy of pre-surgery expectations of pain relief
100205-4	Accuracy of pre-surgery expectations to perform activities of daily living
100206-2	Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities
100207-0	Post-op total score [Knee Society Score]
100208-8	Post-op objective knee indicators score [Knee Society Score]
100209-6	Post-op symptoms score [Knee Society Score]
10021-4	R' wave amplitude in lead V6
100210-4	Post-op patient expectations score [Knee Society Score]
100211-2	Post-op functional activities score [Knee Society Score]
100212-0	Post-op discretionary knee activities score [Knee Society Score]
100213-8	Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method
100214-6	Dental model prior authorization Document
100215-3	Episode of care medical records Document Transplant surgery
100216-1	Surgical synoptic report
100217-9	Surgical oncology synoptic report
100218-7	Surgical oncology of colon synoptic report
100219-5	Surgical oncology of melanoma synoptic report
10022-2	R' wave duration in lead AVF
100220-3	Surgical oncology of breast synoptic report
100221-1	Surgical oncology of thyroid synoptic report
100222-9	Surgical oncology of pancreas synoptic report
100223-7	Physical findings of Retina Narrative
100224-5	Cardiac left ventricular segmental wall motion by echo panel
100225-2	Bone density quantitative ultrasound study
100226-0	Small bowel capsule endoscopy study Document
100227-8	Colon capsule endoscopy study Document
100228-6	Upper gastrointestinal capsule endoscopy study Document
100229-4	Endoscopic ultrasound study Document
10023-0	R' wave duration in lead AVL
100230-2	Routine prenatal assessment panel
100231-0	Endobronchial ultrasound study
100232-8	Impacts of Events Scale-Revised panel
100233-6	Reminders brought back feelings about adverse event
100234-4	Trouble staying asleep
100235-1	Other things triggered persistent thoughts about adverse event
100236-9	Felt irritable AndOr angry
100237-7	Avoided getting upset when unintentionally thought about adverse event
100238-5	Thought about adverse event unintentionally
100239-3	Felt as if adverse event did not happen
10024-8	R' wave duration in lead AVR
100240-1	Avoided reminders of adverse event
100241-9	Experienced mental images of adverse event
100242-7	Easily startled
100243-5	Tried to not think of adverse event
100244-3	Aware of feelings about adverse event, but did not address them
100245-0	Feelings about adverse event were numb
100246-8	Acted or felt the same as during adverse event
100247-6	Trouble falling asleep
100248-4	Waves of strong feelings about adverse event
100249-2	Tried to remove adverse event from memory
10025-5	R' wave duration in lead I
100250-0	Trouble concentrating
100251-8	Reminders of adverse event caused physical reactions
100252-6	Had dreams about adverse event
100253-4	Felt watchful and on-guard
100254-2	Tried not to talk about adverse event
100255-9	Total score [Impact of Event Scale-Revised]
100256-7	Fallen in last 6 months
100257-5	Feel unsteady when standing or walking
100258-3	History of fall related injury
100259-1	Aware of tactile sensations
10026-3	R' wave duration in lead II
100260-9	Easy to describe thoughts AndOr feelings
100261-7	Critical of own thoughts AndOr feelings
100262-5	Able to notice distressing thoughts AndOr feelings without having to react
100263-3	Easily distracted
100264-1	Able to notice thoughts AndOr feelings without being overwhelmed
100265-8	Aware of dietary intake impact on self
100266-6	Difficult to describe thoughts AndOr feelings
100267-4	Aware of auditory stimuli
100268-2	Able to avoid immediate reaction in difficult situations
100269-0	Do things without paying attention
10027-1	R' wave duration in lead III
100270-8	Recover quickly from distressing thoughts AndOr images
100271-6	Aware of olfactory stimuli
100272-4	Aware of visual stimuli
100273-2	Aware of emotions affect on thoughts AndOr behavior
100274-0	Observing score [FFMQ]
100275-7	Describing score [FFMQ]
100276-5	Acting with awareness score [FFMQ]
100277-3	Nonjudging score [FFMQ]
100278-1	Nonreactivity score [FFMQ]
100279-9	Total score [FFMQ]
10028-9	R' wave duration in lead V1
100280-7	Five Facet Mindfulness Questionnaire panel [FFMQ]
100281-5	D Ab [Units/volume] in Serum or Plasma
100282-3	Vaccine exemption certificate
100283-1	Harris Hip Score panel [Harris Hip Score]
100284-9	Walking - functional ability
100285-6	Comfortable seated position
100286-4	Able to board public transportation
100287-2	Put on shoes and socks
100288-0	Absence of deformity score [Harris Hip Score]
100289-8	Absence of hip deformity measurements
10029-7	R' wave duration in lead V2
100290-6	Range of motion score [Harris Hip Score]
100291-4	Total score [Harris Hip Score]
100292-2	Pre-op patient satisfaction score [Knee Society Score]
100293-0	Hip Flexion range of motion
100294-8	Hip Abduction range of motion
100295-5	Hip Adduction range of motion
100296-3	Hip External rotation range of motion
100297-1	Hip Internal rotation range of motion
100298-9	Repetition count
100299-7	Post-op patient satisfaction score [Knee Society Score]
1003-3	Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma
10030-5	R' wave duration in lead V3
100300-3	End time Unspecified body region
100301-1	Start time Unspecified body region
100302-9	Time period start and end panel Unspecified body region
100303-7	Condition certainty of presence
100304-5	Flights climbed [#] Reporting Period
100305-2	IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method
100306-0	IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method
100307-8	Behavioral screening elder mistreatment
100308-6	Need help getting to essential places
100309-4	Activity support person
10031-3	R' wave duration in lead V4
100310-2	Reliability of support person
100311-0	Need help to make sure there is enough food, medicines or any other things needed in house
100312-8	Person or persons that makes sure there is enough food, medicines or any other things needed in house
100313-6	Need help with household things such as cook meals, help feed, or provide correct medicines each day
100314-4	Need help with house cleaning or yard work
100315-1	Need help getting out of bed, showered, or dressed
100316-9	Need help to make sure bills get paid
100317-7	Relationship of usual support person for daily activities
100318-5	Have help with finances AndOr financial decisions
100319-3	Relationship of financial support person
10032-1	R' wave duration in lead V5
100320-1	Financial support person usually asks for permission before making decisions
100321-9	Financial support person usually makes good decisions about finances
100322-7	Have access to paperwork for financial decisions made
100323-5	Financial support person forged signature
100324-3	Coercion of financial support person for signing a document in order to get money or possessions
100325-0	Experienced theft by support person
100326-8	Money spent or property sold without permission
100327-6	Stranger forged signature for financial gain
100328-4	Stranger forced document signature for financial gain
100329-2	Feared for safety due to verbal attack
10033-9	R' wave duration in lead V6
100330-0	Felt humiliated due to ridicule
100331-8	Coerced to do something
100332-6	Ignored by close friend or relative for extended period
100333-4	Physically hit or threatened
100334-2	Been physically hurt with some degree of injury
100335-9	Coerced sexual activity
100336-7	Coerced touching of private body parts of self or others
100337-5	Coerced to undress or expose private body area
100338-3	Photographed in any degree of nudity without consent
100339-1	Experienced attempted physical restraint
10034-7	S wave amplitude in lead AVF
100340-9	Range of motion panel Hip
100341-7	Rubella virus IgG Ab index [Units/volume] in Serum and CSF
100342-5	Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry
100343-3	Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
100344-1	Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
100345-8	Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
100346-6	Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG
100347-4	Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG
100348-2	Model for end-stage liver disease sodium score
100349-0	US.doppler Penis vessels W vasodilator IV
10035-4	S wave amplitude in lead AVL
100350-8	Sesamum indicum 1 IgE Ab [Units/volume] in Serum
100351-6	Pioglitazone [Presence] in Serum or Plasma
100352-4	Rosiglitazone [Presence] in Serum or Plasma
100353-2	Norwalk Community Health Center Screening Tool [NCHC]
100354-0	Frequency of participating in multi-modal communication without assistance
100355-7	Frequency of participating in spoken language expression communication without assistance
100356-5	Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection
100357-3	Naloxone [Presence] in Cord tissue by Screen method
100358-1	Phentermine [Presence] in Cord tissue by Screen method
100359-9	Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay
10036-2	S wave amplitude in lead AVR
100360-7	Brief Resilience Scale panel [BRS]
100361-5	Quickly recover from bad events
100362-3	Difficulty making it through stressful events
100363-1	Easily recover from a stressful event
100364-9	Difficulty recovering from bad events
100365-6	Easily recover from difficulties
100366-4	Lengthy recovery from setbacks
100367-2	Total Score BRS
100368-0	Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS
100369-8	NM Thyroid gland Views W Tl-201 IV
10037-0	S wave amplitude in lead I
100370-6	Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection
100371-4	Titin Ab [Units/volume] in Serum by Immunoassay
100372-2	Abiraterone [Mass/volume] in Serum or Plasma
100373-0	Eucheuma IgG Ab [Units/volume] in Serum
100374-8	Aloe vera IgG Ab [Units/volume] in Serum
100375-5	Anise IgG Ab [Units/volume] in Serum
100376-3	Bambusa vulgaris IgG Ab [Units/volume] in Serum
100377-1	Goat cheese IgG Ab [Units/volume] in Serum
100378-9	Sheep cheese IgG Ab [Units/volume] in Serum
100379-7	Leeks IgG Ab [Units/volume] in Serum
10038-8	S wave amplitude in lead II
100380-5	Red cabbage IgG Ab [Units/volume] in Serum
100381-3	Mentha balsamea Wild IgG Ab [Units/volume] in Serum
100382-1	FDA package insert REMS addressed risk
100383-9	Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection
100384-7	Rapeseed IgG Ab [Units/volume] in Serum
100385-4	Corn salad IgG Ab [Units/volume] in Serum
100386-2	Rosemary IgG Ab [Units/volume] in Serum
100387-0	Poppy Seed IgG Ab [Units/volume] in Serum
100388-8	Cocoa IgG Ab [Units/volume] in Serum
100389-6	Pistachio IgG Ab [Units/volume] in Serum
10039-6	S wave amplitude in lead III
100390-4	Sunflower Seed IgG Ab [Units/volume] in Serum
100391-2	Dates IgG Ab [Units/volume] in Serum
100392-0	Duck meat IgG Ab [Units/volume] in Serum
100393-8	Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum
100394-6	Astacoidea IgG Ab [Units/volume] in Serum
100395-3	Carob IgG Ab [Units/volume] in Serum
100396-1	Brassica napus IgG Ab [Units/volume] in Serum
100397-9	Goat Meat IgG Ab [Units/volume] in Serum
100398-7	Goose meat IgG Ab [Units/volume] in Serum
100399-5	Ostrich meat IgG Ab [Units/volume] in Serum
1004-1	Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells
10040-4	S wave amplitude in lead V1
100400-1	Quail meat IgG Ab [Units/volume] in Serum
100401-9	Rabbit meat IgG Ab [Units/volume] in Serum
100402-7	Venison meat IgG Ab [Units/volume] in Serum
100403-5	Guineafowl IgG Ab [Units/volume] in Serum
100404-3	Horse meat IgG Ab [Units/volume] in Serum
100405-0	Kefir IgG Ab [Units/volume] in Serum
100406-8	Butter IgG Ab [Units/volume] in Serum
100407-6	Camembert cheese IgG Ab [Units/volume] in Serum
100408-4	Emmental cheese IgG Ab [Units/volume] in Serum
100409-2	Processed cheese IgG Ab [Units/volume] in Serum
10041-2	S wave amplitude in lead V2
100410-0	Curd cheese IgG Ab [Units/volume] in Serum
100411-8	Sugar Beet IgG Ab [Units/volume] in Serum
100412-6	Chinese cabbage IgG Ab [Units/volume] in Serum
100413-4	Fennel Fresh IgG Ab [Units/volume] in Serum
100414-2	Gourd IgG Ab [Units/volume] in Serum
100415-9	Kale IgG Ab [Units/volume] in Serum
100416-7	Savoy cabbage IgG Ab [Units/volume] in Serum
100417-5	Vitis sp leaf IgG Ab [Units/volume] in Serum
100418-3	Liquorice IgG Ab [Units/volume] in Serum
100419-1	Snow pea IgG Ab [Units/volume] in Serum
10042-0	S wave amplitude in lead V3
100420-9	Fava bean IgG Ab [Units/volume] in Serum
100421-7	Chick Pea IgG Ab [Units/volume] in Serum
100422-5	Chicory IgG Ab [Units/volume] in Serum
100423-3	Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum
100424-1	8(9)-Cholestenol [Mass/volume] in Serum or Plasma
100425-8	DiHydro T-Mas [Mass/volume] in Serum or Plasma
100426-6	Squalene [Mass/volume] in Serum or Plasma
100427-4	Stigmasterol [Mass/volume] in Serum or Plasma
100428-2	Carnitine free and total and acylcarnitine panel - Urine
100429-0	LRBA deficiency panel - Blood
10043-8	S wave amplitude in lead V4
100430-8	Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC)
100431-6	Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC)
100432-4	Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC)
100433-2	Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC)
100434-0	Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection
100435-7	Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay
100436-5	Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay
100437-3	Norsufentanil [Mass/volume] in Urine by Confirmatory method
100438-1	Adolescent medicine Outpatient Progress note
100439-9	Allergy and Immunology Outpatient Progress note
10044-6	S wave amplitude in lead V5
100440-7	Allergy Outpatient Progress note
100441-5	Attending Outpatient Progress note
100442-3	Audiology Outpatient Progress note
100443-1	Bariatric surgery Outpatient Progress note
100444-9	Blood banking and transfusion medicine Outpatient Progress note
100445-6	Bone Marrow Transplant Outpatient Progress note
100446-4	Breastfeeding Outpatient Progress note
100447-2	Burn management Outpatient Progress note
100448-0	Cardiac surgery Outpatient Progress note
100449-8	Cardiopulmonary Outpatient Progress note
10045-3	S wave amplitude in lead V6
100450-6	Child and adolescent psychiatry Outpatient Progress note
100451-4	Chiropractic medicine Outpatient Progress note
100452-2	Clinical cardiac electrophysiology Outpatient Progress note
100453-0	Clinical genetics Outpatient Progress note
100454-8	Clinical neurophysiology Outpatient Progress note
100455-5	Clinical pathology Outpatient Progress note
100456-3	Colon and rectal surgery Outpatient Progress note
100457-1	Consultant Outpatient Progress note
100458-9	Outpatient COVID-19 Intubation Progress note
100459-7	Outpatient COVID-19 Progress note
10046-1	S wave duration in lead AVF
100460-5	Dermatology Outpatient Progress note
100461-3	Developmental-behavioral pediatrics Outpatient Progress note
100462-1	Dialysis and Therapeutic apheresis Outpatient Progress note
100463-9	Eating disorders Outpatient Progress note
100464-7	Endocrinology Outpatient Progress note
100465-4	Family medicine Outpatient Progress note
100466-2	Gastroenterology Outpatient Progress note
100467-0	Geriatric medicine Outpatient Progress note
100468-8	Gynecologic oncology Outpatient Progress note
100469-6	Gynecology Outpatient Progress note
10047-9	S wave duration in lead AVL
100470-4	Healthcare navigator Outpatient Progress note
100471-2	Heart failure Outpatient Progress note
100472-0	Heart failure+Transplant cardiology Outpatient Progress note
100473-8	Hematology Outpatient Progress note
100474-6	Hematology+Medical oncology Outpatient Progress note
100475-3	Hepatology Outpatient Progress note
100476-1	Immunology Outpatient Progress note
100477-9	Infectious disease Outpatient Progress note
100478-7	Internal medicine Outpatient Progress note
100479-5	Interventional cardiology Outpatient Progress note
10048-7	S wave duration in lead AVR
100480-3	Interventional radiology Outpatient Progress note
100481-1	Outpatient Mechanical circulatory support Progress note
100482-9	Medical Aid in Dying Outpatient Progress note
100483-7	Mental health Outpatient Progress note
100484-5	Multi-specialty program Outpatient Progress note
100485-2	Neonatal perinatal medicine Outpatient Progress note
100486-0	Nephrology Outpatient Progress note
100487-8	Neurological surgery Outpatient Progress note
100488-6	Neurology Outpatient Progress note
100489-4	Neurology with special qualifications in child neurology Outpatient Progress note
10049-5	S wave duration in lead I
100490-2	Nurse practitioner Outpatient Progress note
100491-0	Nurse Outpatient Progress note
100492-8	Nutrition and dietetics Outpatient Progress note
100493-6	Obstetrics and Gynecology Outpatient Progress note
100494-4	Obstetrics Outpatient Progress note
100495-1	Occupational therapy Outpatient Progress note
100496-9	Oncology Outpatient Progress note
100497-7	Ophthalmology Outpatient Progress note
100498-5	Optometry Outpatient Progress note
100499-3	Oral and Maxillofacial Surgery Outpatient Progress note
1005-8	Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma
10050-3	S wave duration in lead II
100500-8	Orthopaedic surgery Outpatient Progress note
100501-6	Orthotics prosthetics Outpatient Progress note
100502-4	Otolaryngology Outpatient Progress note
100503-2	Pain medicine Outpatient Progress note
100504-0	Palliative care Outpatient Progress note
100505-7	Pediatric cardiology Outpatient Progress note
100506-5	Pediatric dermatology Outpatient Progress note
100507-3	Pediatric endocrinology Outpatient Progress note
100508-1	Pediatric gastroenterology Outpatient Progress note
100509-9	Pediatric hematology-oncology Outpatient Progress note
10051-1	S wave duration in lead III
100510-7	Pediatric infectious diseases Outpatient Progress note
100511-5	Pediatric otolaryngology Outpatient Progress note
100512-3	Pediatric pulmonology Outpatient Progress note
100513-1	Pediatric rheumatology Outpatient Progress note
100514-9	Pediatric surgery Outpatient Progress note
100515-6	Pediatric transplant hepatology Outpatient Progress note
100516-4	Pediatric urology Outpatient Progress note
100517-2	Pharmacogenomics Outpatient Progress note
100518-0	Physical medicine and rehab Outpatient Progress note
100519-8	Physical therapy Outpatient Progress note
10052-9	S wave duration in lead V1
100520-6	Plastic surgery Outpatient Progress note
100521-4	Podiatry Outpatient Progress note
100522-2	Psychiatry Hospital Progress note
100523-0	Psychology Outpatient Progress note
100524-8	Pulmonary Outpatient Progress note
100525-5	Radiation oncology Outpatient Progress note
100526-3	Radiology Outpatient Progress note
100527-1	Recreational therapy Outpatient Progress note
100528-9	Reproductive endocrinology and infertility Outpatient Progress note
100529-7	Research Outpatient Progress note
10053-7	S wave duration in lead V2
100530-5	Rheumatology Outpatient Progress note
100531-3	Sleep medicine Outpatient Progress note
100532-1	Social worker Outpatient Progress note
100533-9	Solid Organ Transplant Outpatient Progress note
100534-7	Speech-language pathology Outpatient Progress note
100535-4	Spinal surgery Outpatient Progress note
100536-2	Sports medicine Outpatient Progress note
100537-0	Surgery of the hand Outpatient Progress note
100538-8	Telehealth+Outpatient Progress note
100539-6	Thromboembolism Outpatient Progress note
10054-5	S wave duration in lead V3
100540-4	Transplant surgery Outpatient Progress note
100541-2	Trauma Outpatient Progress note
100542-0	Urology Outpatient Progress note
100543-8	Vascular neurology Outpatient Progress note
100544-6	Vascular surgery Outpatient Progress note
100545-3	Wound care management Outpatient Progress note
100546-1	Wound, Ostomy, and Continence Care Outpatient Progress note
100547-9	Adolescent medicine Hospital Progress note
100548-7	Allergy and Immunology Hospital Progress note
100549-5	Allergy Hospital Progress note
10055-2	S wave duration in lead V4
100550-3	Attending Hospital Progress note
100551-1	Audiology Hospital Progress note
100552-9	Bariatric surgery Hospital Progress note
100553-7	Blood banking and transfusion medicine Hospital Progress note
100554-5	Bone Marrow Transplant Hospital Progress note
100555-2	Breastfeeding Hospital Progress note
100556-0	Burn management Hospital Progress note
100557-8	Cardiac surgery Hospital Progress note
100558-6	Cardiopulmonary Hospital Progress note
100559-4	Child and adolescent psychiatry Hospital Progress note
10056-0	S wave duration in lead V5
100560-2	Clinical cardiac electrophysiology Hospital Progress note
100561-0	Clinical genetics Hospital Progress note
100562-8	Clinical neurophysiology Hospital Progress note
100563-6	Clinical pathology Hospital Progress note
100564-4	Colon and rectal surgery Hospital Progress note
100565-1	Consultant Hospital Progress note
100566-9	Dentistry Hospital Progress note
100567-7	Dermatology Hospital Progress note
100568-5	Developmental-behavioral pediatrics Hospital Progress note
100569-3	Dialysis and Therapeutic apheresis Hospital Progress note
10057-8	S wave duration in lead V6
100570-1	Eating disorders Hospital Progress note
100571-9	Endocrinology Hospital Progress note
100572-7	Family medicine Hospital Progress note
100573-5	Gastroenterology Hospital Progress note
100574-3	General medicine Hospital Progress note
100575-0	Geriatric medicine Hospital Progress note
100576-8	Gynecologic oncology Hospital Progress note
100577-6	Gynecology Hospital Progress note
100578-4	Healthcare navigator Hospital Progress note
100579-2	Heart failure Hospital Progress note
10058-6	S' wave amplitude in lead AVF
100580-0	Heart failure+Transplant cardiology Hospital Progress note
100581-8	Hematology Hospital Progress note
100582-6	Hematology+Medical oncology Hospital Progress note
100583-4	Hepatology Hospital Progress note
100584-2	Immunology Hospital Progress note
100585-9	Infectious disease Hospital Progress note
100586-7	Internal medicine Hospital Progress note
100587-5	Interventional cardiology Hospital Progress note
100588-3	Interventional radiology Hospital Progress note
100589-1	Hospital Mechanical circulatory support Progress note
10059-4	S' wave amplitude in lead AVL
100590-9	Medical Aid in Dying Hospital Progress note
100591-7	Mental health Hospital Progress note
100592-5	Multi-specialty program Hospital Progress note
100593-3	Neonatal perinatal medicine Hospital Progress note
100594-1	Nephrology Hospital Progress note
100595-8	Neurological surgery Hospital Progress note
100596-6	Neurology Hospital Progress note
100597-4	Neurology with special qualifications in child neurology Hospital Progress note
100598-2	Nurse practitioner Hospital Progress note
100599-0	Nurse Hospital Progress note
1006-6	Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells
10060-2	S' wave amplitude in lead AVR
100600-6	Nutrition and dietetics Hospital Progress note
100601-4	Obstetrics and Gynecology Hospital Progress note
100602-2	Obstetrics Hospital Progress note
100603-0	Occupational therapy Hospital Progress note
100604-8	Oncology Hospital Progress note
100605-5	Ophthalmology Hospital Progress note
100606-3	Oral and Maxillofacial Surgery Hospital Progress note
100607-1	Orthopaedic surgery Hospital Progress note
100608-9	Orthotics prosthetics Hospital Progress note
100609-7	Otolaryngology Hospital Progress note
10061-0	S' wave amplitude in lead I
100610-5	Pain medicine Hospital Progress note
100611-3	Palliative care Hospital Progress note
100612-1	Pastoral care Hospital Progress note
100613-9	Pediatric cardiology Hospital Progress note
100614-7	Pediatric dermatology Hospital Progress note
100615-4	Pediatric endocrinology Hospital Progress note
100616-2	Pediatric gastroenterology Hospital Progress note
100617-0	Pediatric hematology-oncology Hospital Progress note
100618-8	Pediatric infectious diseases Hospital Progress note
100619-6	Pediatric otolaryngology Hospital Progress note
10062-8	S' wave amplitude in lead II
100620-4	Pediatric pulmonology Hospital Progress note
100621-2	Pediatric rheumatology Hospital Progress note
100622-0	Pediatric surgery Hospital Progress note
100623-8	Pediatric transplant hepatology Hospital Progress note
100624-6	Pharmacogenomics Hospital Progress note
100625-3	Pharmacology Hospital Progress note
100626-1	Physical medicine and rehab Hospital Progress note
100627-9	Physical therapy Hospital Progress note
100628-7	Plastic surgery Hospital Progress note
100629-5	Podiatry Hospital Progress note
10063-6	S' wave amplitude in lead III
100630-3	Psychology Hospital Progress note
100631-1	Radiation oncology Hospital Progress note
100632-9	Radiology Hospital Progress note
100633-7	Rapid response team Hospital Progress note
100634-5	Recreational therapy Hospital Progress note
100635-2	Reproductive endocrinology and infertility Hospital Progress note
100636-0	Research Hospital Progress note
100637-8	Rheumatology Hospital Progress note
100638-6	Sleep medicine Hospital Progress note
100639-4	Social worker Hospital Progress note
10064-4	S' wave amplitude in lead V1
100640-2	Solid Organ Transplant Hospital Progress note
100641-0	Speech-language pathology Hospital Progress note
100642-8	Spinal surgery Hospital Progress note
100643-6	Surgery of the hand Hospital Progress note
100644-4	Thromboembolism Hospital Progress note
100645-1	Trauma Hospital Progress note
100646-9	Urology Hospital Progress note
100647-7	Vascular neurology Hospital Progress note
100648-5	Vascular surgery Hospital Progress note
100649-3	Wound care management Hospital Progress note
10065-1	S' wave amplitude in lead V2
100650-1	Wound, Ostomy, and Continence Care Hospital Progress note
100651-9	Hospital COVID-19 Intubation Progress note
100652-7	Pure tone bone conduction threshold audiometry panel
100653-5	Pure tone air conduction threshold audiometry panel
100654-3	Pyruvate kinase M2 [Presence] in Stool
100655-0	XR Sella turcica Lateral
100656-8	Maternal and fetal medicine Outpatient Progress note
100657-6	Maternal and fetal medicine Telephone encounter+Hospital Progress note
100658-4	Hospital COVID-19 Progress note
100659-2	Maternal and fetal medicine Hospital Progress note
10066-9	S' wave amplitude in lead V3
100660-0	Maternal and fetal medicine Telephone encounter+Outpatient Progress note
100661-8	Psychiatry Outpatient Progress note
100662-6	Cortisol free and total panel - Serum or Plasma
100663-4	TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method
100664-2	NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method
100665-9	NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method
100666-7	NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method
100667-5	NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method
100668-3	NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method
100669-1	NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method
10067-7	S' wave amplitude in lead V4
100670-9	RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus
100671-7	Aspergillus sp DNA [Presence] in Blood by NAA with probe detection
100672-5	Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection
100673-3	Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection
100674-1	BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100675-8	Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
100676-6	Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection
100677-4	Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
100678-2	Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100679-0	Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
10068-5	S' wave amplitude in lead V5
100680-8	Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100681-6	Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
100682-4	Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100683-2	Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
100684-0	Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100685-7	JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
100686-5	JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
100687-3	JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection
100688-1	Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100689-9	Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection
10069-3	S' wave amplitude in lead V6
100690-7	Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection
100691-5	Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
100692-3	Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
100693-1	Pneumocystis jiroveci DNA [Log #/volume] in Respiratory specimen by NAA with probe detection
100694-9	SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method
100695-6	Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative
100696-4	CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal
100697-2	Interventional radiology Outpatient Note
100698-0	Social Determinants of Health screening report Document
100699-8	Rifabutin+Ethambutol [Susceptibility]
1007-4	Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10070-1	S' wave duration in lead AVF
100700-4	Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection
100701-2	Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection
100702-0	Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection
100703-8	Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection
100704-6	Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection
100705-3	Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection
100706-1	Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection
100707-9	Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count
100708-7	Plasma cells/100 leukocytes in Synovial fluid
100709-5	Hepatocellular carcinoma risk [Score] by GAAD
10071-9	S' wave duration in lead AVL
100710-3	Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection
100711-1	Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay
100712-9	Brexpiprazole [Mass/volume] in Serum or Plasma
100713-7	Cariprazine [Mass/volume] in Serum or Plasma
100714-5	Guanfacine [Mass/volume] in Serum or Plasma
100715-2	Prothipendyl [Mass/volume] in Serum or Plasma
100716-0	Prostate specific Ag [Mass/volume] in DBS
100717-8	FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method
100718-6	Undersea and hyperbaric medicine Discharge summary
100719-4	Surgical oncology Discharge summary
10072-7	S' wave duration in lead AVR
100720-2	Reproductive endocrinology and infertility Discharge summary
100721-0	Community health care Discharge summary
100722-8	Integrative medicine Discharge summary
100723-6	Sports medicine Discharge summary
100724-4	Diabetology Discharge summary
100725-1	Optometry Discharge summary
100726-9	Podiatry Discharge summary
100727-7	Chiropractic medicine Discharge summary
100728-5	Cardiac surgery Discharge summary
100729-3	Breastfeeding Discharge summary
10073-5	S' wave duration in lead I
100730-1	Transplant surgery Discharge summary
100731-9	Urgent care center Discharge summary
100732-7	Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum
100733-5	Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a)
100734-3	traMADol and Metabolites Panel - Urine by Confirmatory method
100735-0	Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes
100736-8	Acylcarnitine Analysis Post Mortem in Specimen Document
100737-6	Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma
100738-4	Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma
100739-2	Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma
10074-3	S' wave duration in lead II
100740-0	Amylase.macromolecular [Presence] in Serum or Plasma
100741-8	Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma
100742-6	Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma
100743-4	Lipase.macromolecular [Presence] in Serum or Plasma
100744-2	Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis
100745-9	Chloride [Moles/volume] in Mixed venous blood
100746-7	Glucose [Moles/volume] in Mixed venous blood
100747-5	Legionella serogroup panel - Specimen
100748-3	Legionella spp [Presence] in Specimen by NAA with probe detection
100749-1	Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection
10075-0	S' wave duration in lead III
100750-9	Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection
100751-7	Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma
100752-5	Exacerbating factors - Reported
100753-3	Alleviating factors - Reported
100754-1	Platelet disorders multigene analysis in Blood or Tissue by Sequencing
100755-8	Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing
100756-6	Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing
100757-4	Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing
100758-2	Estimated lung age by based on clinical data
100759-0	Inspiratory reserve [Volume] Respiratory system by Spirometry
10076-8	S' wave duration in lead V1
100760-8	XR Radius and Ulna - left Single view
100761-6	PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
100762-4	HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method
100763-2	Mycobacterium sp comparative reaction interpretation Narrative
100764-0	Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal
100765-7	Homocysteine and methylmalonate and methylcitrate panel - DBS
100766-5	Center for Epidemiologic Studies Depression Scale panel [CES-D]
100767-3	Bothered by things that are not usually bothersome
100768-1	Poor appetite
100769-9	Unhappy even with help from my family or friends
10077-6	S' wave duration in lead V2
100770-7	Feeling just as good as others
100771-5	Trouble focusing
100772-3	Feeling depressed
100773-1	Feeling everything is too much of an effort
100774-9	Feeling hopeful about the future
100775-6	Feeling life had been a failure
100776-4	Feeling fearful
100777-2	Restless sleep
100778-0	Feeling happy
100779-8	Quieter than usual
10078-4	S' wave duration in lead V3
100780-6	Feeling lonely
100781-4	People were unfriendly
100782-2	Enjoying life
100783-0	Crying spells
100784-8	Feeling sad
100785-5	Feeling people dislike me
100786-3	Lack of energy
100787-1	Total Score CES-D
100788-9	Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum
100789-7	Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum
10079-2	S' wave duration in lead V4
100790-5	Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum
100791-3	Hamster epithelium IgG Ab [Mass/volume] in Serum
100792-1	Forsythia IgE Ab [Units/volume] in Serum
100793-9	Testosterone [Mass/volume] in Body fluid
100794-7	Follitropin [Units/volume] in Body fluid
100795-4	S100 calcium binding protein B [Mass/volume] in Body fluid
100796-2	Thyroglobulin [Mass/volume] in Body fluid
100797-0	Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge
100798-8	Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge
100799-6	21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge
1008-2	Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma
10080-0	S' wave duration in lead V5
100800-2	21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge
100801-0	21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge
100802-8	21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge
100803-6	21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge
100804-4	Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge
100805-1	Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge
100806-9	Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge
100807-7	Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge
100808-5	Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge
100809-3	Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge
10081-8	S' wave duration in lead V6
100810-1	Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge
100811-9	Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge
100812-7	Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge
100813-5	Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge
100814-3	Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge
100815-0	Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge
100816-8	Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
100817-6	Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
100818-4	Renin [Mass/volume] in Plasma --1st specimen post XXX challenge
100819-2	Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge
10082-6	ST initial amplitude 6 ms in lead AVF
100820-0	Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge
100821-8	National POLST form: portable medical order panel
100822-6	Cardiopulmonary resuscitation orders
100823-4	Initial portable medical treatment orders
100824-2	Additional portable medical orders or instructions
100825-9	Medically assisted nutrition orders
100826-7	Portable medical order AndOr advance directive review
100827-5	Portable medical order discussion participants
100828-3	Portable medical order administrative information
100829-1	Renin [Mass/volume] in Plasma --4th specimen post XXX challenge
10083-4	ST initial amplitude 6 ms in lead AVL
100830-9	Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge
100831-7	Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge
100832-5	Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge
100833-3	Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge
100834-1	Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge
100835-8	Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge
100836-6	Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge
100837-4	Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
100838-2	Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
100839-0	Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma
10084-2	ST initial amplitude 6 ms in lead AVR
100840-8	IgE [Units/volume] in Body fluid
100841-6	Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot
100842-4	Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST
100843-2	Liver fibrosis score in Serum or Plasma by Calculated.Agile3+
100844-0	Liver fibrosis score in Serum or Plasma by Calculated.Agile4
100845-7	Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC)
100846-5	Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay
100847-3	Gas and ammonia panel - Arterial blood
100848-1	Cell count and Differential panel - Amniotic fluid by Manual count
100849-9	Leukocytes [#/volume] in Amniotic fluid by Manual count
10085-9	ST initial amplitude 6 ms in lead I
100850-7	Neutrophils [#/volume] in Amniotic fluid by Manual count
100851-5	Other cells [#/volume] in Amniotic fluid by Manual count
100852-3	NM Bones Views for metastasis W Sr-89 IV
100853-1	NM Pericardial space Pericardial effusion
100854-9	Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay
100855-6	CD3 cells/100 cells in Blood mononuclear cells
100856-4	CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells
100857-2	CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells
100858-0	Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
100859-8	Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
10086-7	ST initial amplitude 6 ms in lead II
100860-6	Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
100861-4	Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
100862-2	Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
100863-0	Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
100864-8	Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method
100865-5	Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection
100866-3	Febrile antibody profile in Serum
100867-1	Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay
100868-9	Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method
100869-7	Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method
10087-5	ST initial amplitude 6 ms in lead III
100870-5	Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method
100871-3	Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method
100872-1	Bacteria producing polysaccharide from sucrose [Presence] in Isolate
100873-9	Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method
100874-7	Basidiobolus sp [Presence] in Specimen
100875-4	Fetal Heart Document limited US
100876-2	Fetal Heart Document US
100877-0	US Heart Transesophageal during surgery
100878-8	Endoscopic ultrasound study Upper GI tract Document
100879-6	US Guidance for cryoablation of Breast - right
10088-3	ST initial amplitude 6 ms in lead V1
100880-4	US Guidance for cryoablation of Breast - left
100881-2	MR Guidance for cryoablation of Bone
100882-0	MR Peritoneum W contrast percutaneous intraperitoneal
100883-8	MR Guidance for biopsy of Kidney - left
100884-6	MR Guidance for biopsy of Kidney - right
100885-3	Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection
100886-1	Orf virus DNA [Presence] in Specimen by NAA with probe detection
100887-9	Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection
100888-7	West African monkeypox virus DNA [Presence] in Specimen by NAA with probe detection
100889-5	Congo Basin monkeypox virus DNA [Presence] in Specimen by NAA with probe detection
10089-1	ST initial amplitude 6 ms in lead V2
100890-3	Poxvirus DNA panel
100891-1	Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay
100892-9	Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay
100893-7	Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma
100894-5	Recommended screening frequency Narrative
100895-2	Rickettsia conorii IgG and IgM [Interpretation] in Serum
100896-0	Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge
100897-8	Staphylococcus aureus [Presence] in Specimen by Organism specific culture
100898-6	Lipid panel - Serum or Plasma
100899-4	Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture